Home/Search
2020 Scientific Sessions
Satellite Sessions
Hypercoagulability and Antithrombotic Recommendations During the COVID-19 Pandemic
Case: Thrombotic and Thromboembolic Cardiac Complications, The European Experience
Alaide Chieffo, M.D.
Case: Thrombotic and Thromboembolic Cardiac Complications, The U.S. Experience
Binita Shah, M.D., FSCAI
Potential Mechanisms of COVID Hypercoagulopathy
Joshua Beckman, MD, MSc
Identifying Patients at Risk, Prophylaxis and Management of Arterial and Venous Thrombotic Events
Geoffrey Barnes, M.D.
Unintended Consequences of Stay-at-Home Orders: Cardiac Events in Non-COVID Patients
Cindy L. Grines, M.D., MSCAI
Intravenous Platelet Inhibition in PCI: Case-Based Look at Expanding Applications
The Data for IV Platelet Inhibition in High-risk Patients: Which Patients Benefit the Most?
Roxana Mehran, M.D., MSCAI
COVID-19-Related Coagulopathies
Luis Gruberg, M.D., FSCAI
IV Platelet Inhibition in Cardiogenic Shock: When to Use and for How Long?
Timothy D. Henry, M.D., MSCAI
IV Antiplatelet Therapy in the ICU: A When-to-and-How-to Guide in the Era of COVID
Perwaiz M. Meraj, M.D., FSCAI
Case with Panel Discussion: PCI in Complex Stable CAD
Matthew J. Price, MD
LDL Management for the Interventionalist
The Impact of PCSK-9 Inhibition of Coronary Plaque: GLAGOV and Beyond
Subhash Banerjee, M.D., FSCAI
PCSK-9 Inhibition: Clinical Trial Data
Payal Kohli, MD
LDL Management: Guideline Recommendations
Michael H. Davidson, MD
Lipid Lowering in the COVID Era
Thomas Knickelbine, M.D.
Management of Complex Coronary Lesions—Optimizing cPCI in a Dynamic Environment
Case Introduction
M Chadi Alraies, MD, FSCAI
Indications and Rationale for Hemodynamic Support in Complex Coronary Lesions
David E. Kandzari, M.D., FSCAI
The Importance of Intracoronary Imaging in the Treatment of Complex and Calcified Lesions
Kathleen Kearney, M.D., FSCAI
The Role of Atherectomy in the Management of Severely Calcified Lesions
Sunil V. Rao, MD, FSCAI
Case Resolution
M Chadi Alraies, MD, FSCAI
Management of the cPCI Patient: CTO, Bifurcations, and High Bleeding Risk
Complex Bifurcations: Tips, Tricks and Troubleshooting
Mitul P. Patel, M.D., FSCAI
CTO PCI: Common Difficult Scenarios and How I Troubleshoot
Arasi Maran, M.D., FSCAI
High Bleeding Risk Patients Undergoing PCI: How I Assess and Treat to Optimize Outcomes
Robert W. Yeh, M.D., FSCAI
Polyvascular Disease, Secondary Prevention in PVI Patients With PVD
Identification of Patients with Polyvascular Disease: Is There a Role for Screening or Systematic Identification?
Ehrin J. Armstrong, M.D.
Antithrombotic Agents for Patients With Polyvascular Disease and After Peripheral Vascular Intervention
Marc P. Bonaca, MD, MPH
PSCK9 Inhibitors for Patients With Polyvascular Disease
Dharam J. Kumbhani, M.D., FSCAI
Combined Treatment of Coronary and Peripheral Artery Disease: Case Examples
Sahil A. Parikh, MD, FSCAI
SCAI TRAnsition for VALUE: Incorporating Prior Bypass Patients Into Your TRA cPCI Practice
Taking Your Transradial Practice to the Next Level Saphenous Vein Graft (SVG) & internal mammary artery (IMA) graft Diagnostic and PCI: Tips and Tricks
Arasi Maran, M.D., FSCAI
Case Presentation: Complex SVG Transradial PCI
Rhian E. Davies, DO MS, FSCAI
Case Presentation: IMA Transradial PCI
Denada Palm, M.D.
Mini Debate: All This Headache Is Not Worth It. CABG Patients Should be Done Transfemorally
Kathleen Kearney, M.D., FSCAI
Mini Debate: CABG Patients Are High Risk. Transradial Makes Perfect Sense and Is More Efficient
Kusum Lata, M.D., FSCAI
TAVR in the COVID-19 Era and Beyond
Optimizing Your TAVR Program During the COVID-19 Pandemic
Bassem M. Chehab, M.D., FSCAI
Best Practice: TAVR 2020
Pinak Bipin Shah, M.D., FSCAI
Heart Team Decisions: Making the Hard Calls in the Low-Risk Patient
Steven R. Bailey, M.D., MSCAI
The Low-Risk TAVR Patient: Considerations in 2020
Critical Review of the Evidence: Bicuspid in Low-Risk Patients
John K. Forrest, MD
Case Reviews From Low Risk Bicuspid Trial
Stanley J. Chetcuti, M.D., FSCAI
Treating Low-Risk Patients: Why Maximizing Hemodynamic and Avoiding PPM Should Become a Priority
Hasan Jilaihawi, M.D.
How to Optimize Coronary Intervention Therapy in TAVR
James E. Harvey, M.D., FSCAI
Transcatheter Mitral Valve Repair and Replacement: Selection, Therapy, and Outcomes
Optimal Outcomes and Centers of Excellence for Transcatheter Mitral Therapy
Megan Coylewright, M.D., FSCAI
Real-World Outcomes of Transcatheter Mitral Valve Repair
D. Scott Lim, M.D.
Evidence, Rationale, and Outcomes of Transcatheter Mitral Valve Replacement
Mario Goessl, M.D., FSCAI
Best Practices for Practice Growth in Transcatheter Mitral Therapy
Molly Szerlip, M.D., FSCAI